Business Wire
Dr. Reddy’s Announces USFDA Acceptance to Review Its Biologics License Application (BLA) for Proposed Interchangeable Biosimilar, Abatacept
📈
AI Sentiment
Highly Positive
8/10
Dr. Reddy's Laboratories Ltd News
Latest updates and market news for RDY
1 news
Feb 18 - Feb 24, 2026
Page 1
Share this news page